- Home
- KMT vs XENE Comparison
KMT vs XENE Comparison
Compare KMT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KMT | XENE |
|---|---|---|
| Founded | 1938 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KMT | XENE |
|---|---|---|
| Price | $38.78 | $58.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $36.00 | ★ $67.17 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,966,845,000.00 | $311,000.00 |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $7.27 | $2,436.26 |
| P/E Ratio | $52.45 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.62 | $28.19 |
| 52 Week High | $42.03 | $62.91 |
Technical Indicators
Market Signals| Indicator | KMT | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 57.75 | 65.68 |
| Support Level | $37.93 | $39.93 |
| Resistance Level | $41.89 | $59.44 |
| Average True Range (ATR) | 1.23 | 1.92 |
| MACD | 0.37 | -0.15 |
| Stochastic Oscillator | 85.17 | 87.59 |
Price Performance
Historical ComparisonAbout KMT Kennametal Inc.
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.